We’re seeing a good amount of traction in the pharma space and AUROPHARMA is among the top performer. It has recovered almost vertically from the March lows i.e. 288.85 and currently trading at its record high. The reversal of the trend in the pharma space combined with the chart pattern of the stock is indicating a steady rise ahead. We thus advise initiating fresh long positionsin the given range.
BHARTIARTL has been consolidating in a range of 540-590 levels for the past three months while holding firmly above the support zone of 100 EMA on the daily chart. It has again reached closer to the lower band of the range and indications are in the favor of rebound from the current levels. Traders shouldn’t miss this opportunity and accumulate the stock within the mentioned levels.
We’re seeing long term reversal in LUPIN, after a prolonged downtrend of nearly four years. It has not only breached the resistance zone of declining trend line but also surpassed the hurdle of the long term moving averages on multiple time frames. It might consolidate a bit after the recent up move and traders should use that pause to create fresh longs.
TITAN, after the breakout from a consolidation range, is gradually inching higher while holding strongly above the support zone of the long term moving average( 200 EMA) on the daily chart. The current chart pattern and positioning of the indicators are pointing towards a steady up move ahead. We advocate buying the stock within the mentioned zone.
Disclaimer: All stock prices are in INR
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.